Yoseph Shaaltiel, Executive VP, R&D at Protalix BioTherapeutics, Inc. (PLX), bought 14,900 shares at $3.35 ($50K) on 2007-12-17, disclosed to the SEC on 2007-12-26.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.35 | 5,000 | $17K | 33.2% |
| 2 | $3.35 | 100 | $335 | 0.7% |
| 3 | $3.40 | 5,000 | $17K | 33.7% |
| 4 | $3.40 | 4,800 | $16K | 32.4% |
| Total | $3.38 avg | 14,900 | $50K | 100% |
| Filing → |
| PLX | SELL | 2010-06-23 | $371K | — | Filing → |
| PLX | SELL | 2010-05-03 | $89K | — | Filing → |
| PLX | SELL | 2010-04-16 | $9K | — | Filing → |